Table 1

Characteristics of all patients in Ontario, Canada, with nonepithelial cell ovarian cancer who had initial surgery between 1996 and 1998 (n = 1341)

CharacteristicNo. (%) of patients*
Patient
Age, yr
 18–44158 (11.8)
 45–59436 (32.6)
 60–69363 (27.0)
 ≥ 70384 (28.6)
Size of community
 ≥ 1 250 000483 (36.0)
 500 000 – 1 249 999177 (13.2)
 100 000 – 499 999324 (24.2)
 10 000 – 99 999139 (10.4)
 < 10 000178 (13.3)
 Missing40 (3.0)
Income quintile
 First quintile258 (19.2)
 Second quintile245 (18.3)
 Third quintile239 (17.8)
 Fourth quintile272 (20.3)
 Fifth quintile251 (18.7)
 Missing76 (5.7)
Prior diagnosis of cancer
 Yes99 (7.4)
 No1209 (90.2)
 Missing33 (2.5)
Charlson comorbidity score
 0–11279 (95.4)
 ≥ 262 (4.6)
Disease
Stage
 1330 (25.0)
 2164 (12.2)
 3756 (56.0)
 491 (6.8)
Grade
 Undifferentiated21 (1.6)
 Poor570 (42.4)
 Moderate323 (24.0)
 Well189 (14.3)
 NS238 (17.8)
Histologic type
 Serous744 (55.4)
 Nonserous596 (44.6)
Surgical experience
Surgery
 Elective1175 (87.6)
 Urgent117 (8.7)
 Emergent49 (3.7)
Discipline of primary surgeon
 Obstetrician/gynecologist664 (49.5)
 Gynecologic oncologist485 (36.2)
 General surgeon158 (11.8)
 Other15 (1.1)
 Missing19 (1.4)
Surgeon volume (ovarian cancer surgical volume)
 Mean (SD) [median]14.5 (16.5) [4]
 No. patients in 3 yr
  1–2425 (31.7)
  3–9403 (30.0)
  ≥ 10496 (37.0)
  Missing17 (1.3)
Hospital type
 Gynecologic oncologist on staff626 (46.7)
 Regional cancer or teaching centre98 (7.3)
 Community hospital617 (46.0)
Hospital volume
 Mean (SD) [median]42.3 (36) [24]
 No. patients in 3 yr
  1–15515 (38.4)
  16–99721 (53.8)
  ≥ 100104 (7.8)
Length of the operation, mean (SD) [median]110.6 (52.8) [104]
Length of stay in hospital, mean (SD) [median]9.7 (10.6) [7]
Quality indicator
 Inadequate638 (47.6)
 Adequate177 (13.2)
 Undefined526 (39.2)
Days from admission to surgery, mean (SD) [median]2.3 (3.1) [1]
Postsurgical management
Treatment
 Surgery506 (37.7)
 Surgery + CT764 (57.0)
 Surgery + RT38 (2.8)
 Surgery + RT + CT33 (2.5)
Outcomes under study
Second operation unrelated to complications (< 5 mo)84 (6.3)
Total deaths documented (median survival time, d)893 (66.6)
  • CT = chemotherapy; NS = not stated; RPDB = Ontario Registered Persons Database; RT = radiotherapy; SD = standard deviation.

  • * Unless otherwise indicated.

  • Mortality defined from chart abstraction and RPDB.